Saturday, December 28, 2024
HomeNews

News

EGFR TKI H002 From Redcloud Bio Completes First Dose In Non-small Cell Lung Cancer

RedCloud Bio (the "Company"), an innovative biotech company integrating structural pharmacology and computational approaches to advance small molecule drug discovery and development, announced completion...

IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has...

AIVITA Biomedical Announces Publication of Phase 1 and Phase 2 Trial Results of its COVID-19 Vaccine Candidate

AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced the publication of safety and efficacy results from Phase 1 and...

StemCyte Announces FDA Approval of IND for a Phase II Clinical Trial

Southern California cord blood regenerative therapeutics company StemCyte is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA)...

Bactolife Receives Usd 5 Million In New Funding To Address Gastrointestinal Infections

Bactolife announced that the Bill & Melinda Gates Foundation has committed, in alignment with the foundation's charitable mission, an investment of USD 5 million...
0FansLike
0FollowersFollow
spot_img

Hot Topics